Breast cancer screening aims to detect breast cancer in healthy women before symptoms appear, assuming early detection leads to better outcomes. Various screening methods are used, such as clinical and self breast exams, mammography, genetic screening, ultrasound, and MRI.
In 1988, the UK launched the world's first national breast cancer screening program, the NHS Breast Screening Programme, which achieved national coverage by the mid-1990s.
Starting in 1998, Medicare began covering annual screening mammography for women aged 40 and older.
In 2002, Singapore initiated its national breast screening program, BreastScreen Singapore, targeting women aged 50-64 for screening every two years. This program stands out as Asia's only publicly funded national breast cancer screening initiative.
In 2003, Canadian breast cancer screening programs varied in their offerings of clinical breast examinations and mammography screening for different age groups. Approximately 61% of women aged 50-69 reported having a mammogram within the past two years.
In 2003, a Cochrane review found that breast self-examination was not associated with lower death rates and increased harms due to the identification of benign lesions and unnecessary biopsies.
In 2005, approximately 68% of U.S. women aged 40-64 had undergone a mammogram in the preceding two years, with varying coverage based on insurance status.
As of 2006, roughly 76% of women aged 53–64 in England had received at least one breast cancer screening in the previous three years.
In 2009, the United States Preventive Services Task Force recommended that women over 50 should undergo mammography screening every two years.
In 2012, the Nordic Cochrane Collection suggested that advancements in diagnosis and treatment might reduce the effectiveness of mammography screening. They concluded that screening might no longer be effective in preventing deaths and raised concerns about misleading information online.
A 2013 Cochrane review estimated that mammography screening for women aged 50-75 resulted in a relative decrease in breast cancer death risk of 15%. However, the analysis of least biased trials showed no significant difference in mortality between screened and unscreened groups.
In 2013, the Cochrane Collaboration stated that the highest quality evidence did not show a decrease in cancer-specific or all-cause mortality due to mammography screening. They highlighted a 30% increase in overdiagnosis and overtreatment, raising questions about the balance of benefits and harms.
A 2016 UK study revealed lower breast cancer screening uptake among women with severe mental illness and those from minority ethnic communities, particularly women of South Asian heritage.
In 2017, the NHS Breast Screening Programme supported a research trial to assess the risks and benefits of screening for women aged 47-49 and 71-73.
In March 2022, the European Commission's Scientific Advice Mechanism suggested extending breast cancer screening to women in their mid-40s.
4 hours ago Mystery Funding Fuels Donald Trump's Second Presidential Term Campaign Efforts
5 hours ago Robert Englund Eyes Freddy Krueger Return for A Nightmare on Elm Street Reboot
6 hours ago Exploring Archaeological Evidence Behind The Legendary Trojan War And Homeric Epics
7 hours ago Ike Barinholtz Coined New Name for Diarrhea Outbreak Linked to Donald Trump
8 hours ago Jurassic Park Actor Sam Neill Dies From Pneumonia
8 hours ago Woman Discovers Animals Trapped Behind Walls During Recent Dog Welfare Check
Lindsey Graham is a prominent American politician serving as the...
Cristiano Ronaldo widely considered one of the greatest footballers captains...
Mitch McConnell is a prominent American politician and the longest-serving...
Elon Musk is a visionary entrepreneur and engineer known for...
Candace Owens is an American conservative political commentator author and...
Bernie Sanders is a prominent American politician and the senior...